Differential autoreceptor control of extracellular 5-HT in guinea pig and rat: Species and regional differences

Psychopharmacology

Volumn 172, Issue 1, 2004, Pages 87-93

  Hughes, Zoë A ^a   Dawson, Lee A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5 HT release; 5 HT1A; 5 HT1B; Antidepressant; Dentate gyrus; Frontal cortex; Microdialysis

Indexed keywords

2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; AUTORECEPTOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DENTATE GYRUS; DORSAL RAPHE NUCLEUS; DRUG EFFECT; DRUG SELECTIVITY; FRONTAL CORTEX; GUINEA PIG; INNERVATION; MALE; MEASUREMENT; MEDIAN RAPHE NUCLEUS; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; SEROTONIN RELEASE; SPECIES DIFFERENCE; WAKEFULNESS;

ANIMALS; AUTORECEPTORS; BRAIN; DENTATE GYRUS; FRONTAL LOBE; GUINEA PIGS; MALE; ORGAN SPECIFICITY; PIPERAZINES; PIPERIDONES; PYRIDINES; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN; SPECIES SPECIFICITY; SPIRO COMPOUNDS;

EID: 1542344509     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1615-7     Document Type: Article

References (49)

1. Adell A, Celada P, Artigas F (2001) The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain. J Neurochem 79:172-182
2. Artigas F, Romero L, de Montigny C, Blier P (1996) Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci 19:378-383
3. Åsberg M, Eriksson B, Martensson B, Traskman-Bendz L, Wagner A (1986) Therapeutic effects of serotonin uptake inhibitors in depression. J Clin Psychiatry 47[Suppl]:23-35
4. Assie MB, Koek W (1996) Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties. Eur J Pharmacol 304:15-21
5. Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM (1989) Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46:243-250
6. Buchsbaum MS, Wu J, De Lisi LE, Holcomb H, Kessler R, Johnson J, King AC, Hazlett E, Langston K, Post RM (1986) Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord 10:137-152
7. Burnet PW, Mead A, Eastwood SL, Lacey K, Harrison PJ, Sharp T (1995) Repeated ECS differentially affects rat brain 5-HT1A and 5-HT2A receptor expression. Neuroreport 6:901-904
8. Casanovas JM, Artigas F (1996) Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways. J Neurochem 67:1945-1952
9. Dawson LA, Nguyen HQ (1998) Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex. Eur J Pharmacol 345:41-46
10. Dawson LA, Nguyen HQ (2000) The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (±)-pindolol. Neuropharmacology 39:1044-1052
11. Dawson LA, Nguyen HQ, Smith DI, Schechter LE (2000) Effects of chronic fluoxetine treatment in the presence and absence of (±)-pindolol: a microdialysis study. Br J Pharmacol 130:797-804
12. Engel G, Gothert M, Hoyer D, Schlicker E, Hillenbrand K (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn Schmiedebergs Arch Pharmacol 332:1-7
13. Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A (1995) A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Eur J Pharmacol 281:81-88
14. Gartside SE, Umbers V, Hajos M, Sharp T (1995) Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br J Pharmacol 115:1064-1070
15. Gaster LM, Ham P, Joiner GF, King FD, Mulholland KR, Wyman PA, Hagan JJ, Price GW, Roberts C, Routledge C, Selkirk J, Slade PD, Middlemiss DN (1998) The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. Ann N Y Acad Sci 861:270-271
16. Gobert A, Millan MJ (1999) Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors. Neuropsychopharmacology 21:268-284
17. Gobert A, Dekeyne A, Millan MJ (2000) The ability of WAY100,635 to potentiate the neurochemical and functional actions of fluoxetine is enhanced by co-administration of SB224,289, but not BRL15572. Neuropharmacology 39:1608-1616
18. Gurling J, Shilliam C, Dourish CT, Routledge C (1994) Elevation of hippocampal 5-HT release in the rat by the selective 5-HT1A receptor antagonist, WAY-100635, is dependent on the phase, of the light-dark cycle. In: Louilot A, Durkin T, Spampinato U, Cador M (eds) Monitoring molecules in neuroscience. Proceedings of the 6th international conference on in vivo methods. pp 211-212
19. Hervas I, Queiroz CM, Adell A, Artigas F (2000) Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat. Br J Pharmacol 130:160-166
20. Hervas I, Vilaro MT, Romero L, Scorza MC, Mengod G, Artigas F (2001) Desensitization of 5-HT1A autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635. Neuropsychopharmacology 24:11-20
21. Hjorth S, Auerbach SB (1994) Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur J Pharmacol 260:251-255
22. Hjorth S, Sharp T (1991) Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci 48:1779-1786
23. Hjorth S, Schlicker E, Carlzon D, Nickel T, Bengtsson HJ, Gothert M (2000) Regional differences in 5-HT1B autoreceptor control of 5-HT release? Soc Neurosci Abstr 25:145.8
24. Hopwood SE, Stamford JA (2001) Multiple 5-HT(1) autoreceptor subtypes govern serotonin release in dorsal and median raphe nuclei. Neuropharmacology 40:508-519
25. Hoyer D, Middlemiss DN (1989) Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol Sci 10:130-132
26. Hughes ZA, Sharp T (1998) Evidence that pindolol lacks the ability to enhance the effect of SSRIs on presynaptic 5-HT function. Br J Pharmacol 125:6P
27. Hughes ZA, Price GW, Duxon MS, Middlemiss DN, Hunter AJ, Heidbreder CA (2000) In vivo neurochemistry reveals a differential role for 5-HT1A and 5-HT1B autoreceptors in the control of 5-HT release in the dentate gyrus of the rat and guinea pig. Soc Neurosci Abstr 25:147.4
28. 1B receptor antagonists and paroxetine on 5-HT in the rat frontal cortex under normal and reverse light conditions. Soc Neurosci Abstr 27:306.18
29. Jacobs BL, Fornal CA (1991) Activity of brain serotonergic neurons in the behaving animal. Pharmacol Rev 43:563-578
30. Krishnan KR, Doraiswamy PM, Figiel GS, Husain MM, Shah SA, Na C, Boyko OB, McDonald WM, Nemeroff CB, Ellinwood EH Jr (1991) Hippocampal abnormalities in depression. J Neuropsychiatry Clin Neurosci 3:387-391
31. Maes M, Meltzer H (1995) The serotonin hypothesis of major depression. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 933-944
32. Martin KF, Hannon S, Phillips I, Heal DJ (1992) Opposing roles for 5-HT1B and 5-HT3 receptors in the control of 5-HT release in rat hippocampus in vivo. Br J Pharmacol 106:139-142
33. McKittrick CR, Blanchard DC, Blanchard RJ, McEwen BS, Sakai RR (1995) Serotonin receptor binding in a colony model of chronic social stress. Biol Psychiatry 37:383-393
34. Middlemiss DN, Bremer ME, Smith SM (1988) A pharmacological analysis of the 5-HT receptor mediating inhibition of 5-HT release in the guinea pig frontal cortex. Eur J Pharmacol 157:101-107
35. Moret C, Briley M (1996) Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain. Eur J Pharmacol 295:189-197
36. Mundey MK, Fletcher A, Marsden CA (1996) Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea pig behaviour and dorsal raphe 5-HT neurone firing. Br J Pharmacol 117:750-756
37. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, London
38. Rapisarda C, Bacchelli B (1977) The brain of the guinea pig in stereotaxic coordinates. Arch Sci Biol 61:1-37
39. Roberts C, Price GW, Jones BJ (1997) The role of 5-HT(1B/1D) receptors in the modulation of 5-hydroxytryptamine levels in the frontal cortex of the conscious guinea pig. Eur J Pharmacol 326:23-30
40. Roberts C, Belenguer A, Middlemiss DN, Routledge C (1998) Differential effects of 5-HT1B/1D receptor antagonists in dorsal and median raphe innervated brain regions. Eur J Pharmacol 346:175-180
41. Roberts C, Boyd DF, Middlemiss DN, Routledge C (1999) Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea pig brain following concurrent 5-HT1A or 5-HT re-uptake site blockade. Neuropharmacology 38:1409-1419
42. Roberts C, Hatcher P, Hagan JJ, Austin NE, Jeffrey P, Wyman P, Gaster LM, Routledge C, Middlemiss DN (2000) The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea pig. Naunyn Schmiedebergs Arch Pharmacol 362:177-183
43. Selkirk JV, Scott C, Ho M, Burton MJ, Watson J, Gaster LM, Collin L, Jones BJ, Middlemiss DN, Price GW (1998) SB-224289 - a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity. Br J Pharmacol 125:202-208
44. Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM (1998) Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry 172:527-532
45. Sharp T, Umbers V, Gartside SE (1997) Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Br J Pharmacol 121:941-946
46. Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1:3-9
47. Starkey SJ, Skingle M (1994) 5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphe nucleus. Neuropharmacology 33:393-402
48. Vertes RP (1991) A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol 313:643-668
49. Vertes RP, Fortin WJ, Crane AM (1999) Projections of the median raphe nucleus in the rat. J Comp Neurol 407:555-582